TriApex Biotechnology
An Industry-Leading Company Providing Clinical Analysis and Testing Services
As an important platform providing integrated solutions and enabling disease-oriented research and development of TriApex, Shanghai TriApex Biotechnology Co., Ltd. (TriApex Biotechnology) provides services including GCLP-compliant bioanalysis of macromolecules and micromolecules, CNAS- and CAP-accredited clinical sample analysis, biobank and medical laboratory. TriApex Biotechnology achieves fast and high-quality data output with abundant R&D experience in the fields of micromolecule, monoclonal antibody, multi-domain, protein, gene therapy and cell therapy. With brilliant resources and top R&D capabilities of TriApex, TriApex Biotechnology is committed to providing various services for hundreds of pharmaceutical companies at home and abroad, improving the depth and scope of services, integrating resources and promoting drug listing for the benefits of patients.
Official WeChat account
Official video account
苏公网安备32011202001081 
Regulatory Policies
Project Management
Global
